ACOG: alphacognition.com Net earnings per share (EPS TTM)
The high scalability of Alpha Cognition (ACOG) is driven by patents for Alzheimer's therapy, which is confirmed by the EPS trend over the last 12 months shown on GURU.Markets; this chart currently stands at -1.12. Alpha Cognition (ACOG) is developing partnerships with neurocenters to improve cognitive functions. Simultaneously, management is establishing distribution networks following the approval of its primary drug, earning the trust of investors.
%20%5Blogo%5D%20ACOG&width=1200&height=400&colorIndex=0&v=mwbxec28.yq-7cu2wow&start=20220704&end=20261111&filename=GURU_Markets_-_ACOG_-_Alpha-Cognition_-_Net-earnings-per-share-EPS-TTM "ACOG Alpha Cognition: Net earnings per share for the last 12 months in the range 11/13/2024 - 11/11/2026 | 👁️GURU.Markets👁️")
Analytical breakdowns and data insights for company Alpha Cognition Inc (ACOG)
- stock price and consensus target price:
- market capitalization information:
- business book valuation details:
- debt level and financial liquidity data:
Debt to Equity Alpha Cognition|ACOG - Long-Term Liabilities to Capital|Short-Term Debt to Capital Alpha Cognition Corp|ACOG - Company Total Indebtedness|Debt to Book Capitalization Ratio Alpha Cognition Inc.|ACOG - Company Long-Term Indebtedness|Company Short-Term Debts Alpha Cognition|Quick Liquidity Indicator alphacognition.com
- earnings and valuation multiples indicators:
ACOG - Profit After Payment of Taxes|Projected Future Earnings Alpha Cognition|ACOG - Business Payback Period|Future Price to Earnings Alpha Cognition Corp|ACOG - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Alpha Cognition Inc.|ACOG - Operating profit before amortization|Net earnings per share (EPS TTM) Alpha Cognition|ACOG - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth alphacognition.com|ACOG - Net earnings per share growth this year|Net earnings per share growth forecast for next year Alpha Cognition
Comprehensive company analysis:ACOG - alphacognition.com
Utilizing external contract manufacturing capacities for compound production reduces capital expenditures for Alpha Cognition (ACOG), directly impacting the bottom line. By analyzing the current trailing 12-month EPS, an investor assesses the net income allocated per share, which enables the determination of real operational efficiency and the fundamental value of the business relative to its market capitalization.
Direct competitors
Biogen Inc. - Net earnings per share (EPS TTM)|Earnings per share for the trailing year NBIX (neurocrine.com)|RGC: Net earnings per share (EPS TTM)|Axsome (AXSM) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months ACAD|XENE: Earnings per share for the trailing year|Net earnings per share (EPS TTM) VKTX|Net earnings per share for the last 12 months supernus.com SUPN|Earnings per share for the last twelve months Catalyst Pharmaceuticals, Inc. CPRX|Denali (DNLI) - Net earnings per one share for the last twelve months|Harmony Pharma - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Biohaven Corp (BHVN)|Amylyx Pharmaceuticals (AMLX) - Earnings per share for the last twelve months|Earnings per share for the last 12 months TRVI|PRAX (Praxis Precision Medicines, Inc.) - Net earnings per share (EPS TTM)|Anavex (AVXL) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months CBLL (CeriBell Corp)|Earnings per share for the last four quarters PRTA|Net earnings per share (EPS TTM) ALEC (Alector)|Net earnings per share for the last four quarters annexonbio.com (ANNX)|OMER - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Neurogene Inc|AC Immune Corp (ACIU) - Earnings per share for the last twelve months|Earnings per share for the last 12 months VYGR|NMRA (Neumora Therapeutics) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) scilexholding.com|Net earnings per share (EPS TTM) TVGN|Net earnings per share for the last 12 months Cognition Therapeutics Inc. CGTX|Earnings per share for the last twelve months Inhibikase IKT|Cassava Pharma (SAVA) - Net earnings per one share for the last twelve months|Assertio Therapeutics - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Coya Therapeutics, Inc. (COYA)|vistagen.com (VTGN) - Earnings per share for the last twelve months|Earnings per share for the last 12 months OVID|ABOS (Acumen Pharma) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months CervoMed Corporation CRVO|Net earnings per share for the last 12 months ATHE (Alterity Therapeutics)|Net earnings per share (EPS TTM) clene.com (CLNN)|Earnings per share for the last twelve months PepGen PEPG|Earnings per share for the trailing year JUNS|RLMD - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Annovis Bio Corporation|GRCE: Net earnings per share (EPS TTM)|fireflyneuro.com (AIFF) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months ANEW Medical|Earnings per share for the last twelve months NRSN|Earnings per share for the last twelve months Reviva Pharmaceuticals Holdings (RVPH)|MTVA: Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) NRXS (NeurAxis, Inc.)|Earnings per share for the trailing year HSDT|Passage Bio Corp - Net earnings per share (EPS TTM)|NEUP - Net earnings per share (EPS TTM)|NERV (Minerva Neurosciences Corp) - Net earnings per share for the last 12 months|Athira Pharma Corp - Earnings per share for the trailing year|ADXN (Addex Therapeutics) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Alzamend (ALZN)|Earnings per share for the last twelve months Cyclerion Therapeutics (CYCN)|PTIX - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) KTTA (Pasithea Therapeutics Corp.)|Net earnings per share for the trailing year Cortigent Inc|ATXI - Earnings per share for the last twelve months|BCLI (brainstorm-cell.com) - Earnings per share for the last 12 months|CARA: Net earnings per share (EPS TTM)|CHRO - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months ELYM|ITCI (Intra-Cellular) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) LBPH|Net earnings per share for the last four quarters marinuspharma.com|Earnings per share for the last twelve months NKGen Biotech NKGN|NeuroBo Pharmaceuticals Inc (NRBO) - Net earnings per one share for the last twelve months|SAGE - Earnings per share for the last twelve months|SNPX (Synaptogenix, Inc) - Earnings per share for the last 12 months|TRVN: Net earnings per share (EPS TTM)|Vigil Neuroscience, Inc. (VIGL) - Net earnings per share (EPS TTM)|WENA (Anew Medical) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Cerevel Therapeutics Inc (CERE)
